Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9

By Dr. Matthew Watson

Conference Call and Webcast Scheduled for December 9, 2020, 4:30 pm ET

Go here to read the rest:
Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9

IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant - January 12th, 2021
T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus - January 12th, 2021
Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units - January 12th, 2021
Qilian International Holding Group Limited Announces Pricing of Initial Public Offering - January 12th, 2021
Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health - January 12th, 2021
Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common... - January 12th, 2021
Addex to Present at the Baader Helvea Swiss Equities Conference - January 12th, 2021
iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 - January 12th, 2021
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study - January 12th, 2021
BetterLife Provides Shareholder Update and 2021 Product Development Roadmap - January 12th, 2021
Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19 - January 12th, 2021
Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation - January 12th, 2021
Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities - January 12th, 2021
Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate - January 12th, 2021
ProMIS Neurosciences Announces Strategic Priorities for 2021 - January 12th, 2021
Adamas to Present at Upcoming H.C. Wainwright Conference - January 5th, 2021
aTyr Pharma Announces Positive Topline Results from Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications - January 5th, 2021
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference - January 5th, 2021
Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference - January 5th, 2021
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team - January 5th, 2021
Genocea to Present at the H.C. Wainwright Virtual BioConnect Conference - January 5th, 2021
Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group - January 5th, 2021
Ligature Therapeutics Launches, Raises USD $6M in Seed Financing - January 5th, 2021
Radius Health Announces Change to its Board of Directors - January 5th, 2021
Franciosi Consulting Reviewing the Science and History of Psychedelic Drug Use for Treating Depression, Anxiety and Addiction - January 5th, 2021
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - January 5th, 2021
Innate’s First NK Cell Engager Selected by Sanofi as Drug Candidate for Development - January 5th, 2021
Roche’s novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designation in combination with Tecentriq for PD-L1-high non-small cell lung... - January 5th, 2021
Nicox Highlights Successful 2020 Development Progress and Clinical Milestones for 2021 - January 5th, 2021
Polyphor to Take Part in Panel Discussion on Novel Oncology Targets at the LifeSci Partners 10th Annual Healthcare Corporate Access Event - January 5th, 2021
ViGeneron signs global collaboration agreement for ophthalmic gene therapy development - January 5th, 2021
Bavarian Nordic to Supply Smallpox Vaccines to Three European Countries - January 5th, 2021
AB2 Bio to Participate in Orphan Disease Panel Discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event - January 5th, 2021
Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference - January 5th, 2021
Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine - January 5th, 2021
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market - January 3rd, 2021
Oyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare Conference - January 3rd, 2021
VAXIL Provides Update on USAMRIID and Oral Experiments - January 3rd, 2021
Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19 - January 3rd, 2021
Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor - January 3rd, 2021
Osmotica Pharmaceuticals plc Receives Complete Response Letter from U.S. Food and Drug Administration for Arbaclofen Extended Release Tablets - January 3rd, 2021
Eve & Co Announces Share Consolidation - January 3rd, 2021
Total number of shares and voting rights in Zealand Pharma at December 31, 2020 - January 3rd, 2021
Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study - January 3rd, 2021
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia - January 3rd, 2021
Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment for Hepatocellular Carcinoma (HCC) - January 3rd, 2021
Avicanna Announces Exercise and Closing of Over-Allotment Option - January 3rd, 2021
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete... - January 3rd, 2021
Tauriga Sciences Inc. Approved to be Corporate Exhibitor at 2021 CTIC Capital Pre-J.P. Morgan Healthcare Investment Summit January 9th-10th, 2021 - January 3rd, 2021
Teligent, Inc. Announces Third Quarter 2020 Results - January 3rd, 2021
Draft Top Tool Reviews - Go Topless! – Product Review by Mike Vaughn - January 3rd, 2021
Vaxil’s Annual and Special Shareholders Meeting and Update on Exercise of Warrants - January 3rd, 2021
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD - December 30th, 2020
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China - December 30th, 2020
Change in Number of Shares and Votes in Immunicum AB (publ) - December 30th, 2020
Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK - December 30th, 2020
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021 - December 30th, 2020
Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors - December 30th, 2020
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy... - December 30th, 2020
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B - December 30th, 2020
Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference - December 30th, 2020
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies - December 30th, 2020
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab... - December 30th, 2020
VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and... - December 30th, 2020
Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021 - December 30th, 2020
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2... - December 30th, 2020
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program - December 30th, 2020
Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference - December 30th, 2020
Eve & Co Announces CAD$1M Private Financing - December 30th, 2020
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update - December 30th, 2020
Medicenna Establishes At-the-Market Sales Facility - December 30th, 2020
MedMira Announces Product Update - December 30th, 2020
Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health - December 28th, 2020
Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with... - December 28th, 2020
Orphazyme provides regulatory update on arimoclomol for NPC - December 28th, 2020
Gritstone Oncology Announces Private Placement Financings Totaling $125 Million - December 28th, 2020
Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 - December 28th, 2020
Better Choice to Begin Trading on the OTCQX - December 28th, 2020
Y-mAbs Announces Sale of Priority Review Voucher - December 28th, 2020
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS) - December 28th, 2020

Global News Feed commento

Comments Off | data

December 2nd, 2020

About... Dr. Matthew Watson

This author published 3404 posts in this site.

Comments are closed.

Previous post - Next post

Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9

By Dr. Matthew Watson

About... Dr. Matthew Watson

Share

Comments are closed.

Categories

Archives

Recommended Sites